Encompass Health Corporation
EHC
Ранг среди акций
#1786
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Цена акции
$121.72
Рыночная капитализация
$12.01B
Изменение (1 день)
-0.15%
Изменение (1 год)
-2.78%
Страна
US
Торговля Encompass Health Corporation (EHC)
Категория
Healthcare
Коэффициент P/E для Encompass Health Corporation (EHC)
Коэффициент P/E на October 2026 TTM: 20.35
Согласно последним финансовым отчетам и цене акций Encompass Health Corporation, текущий P/E (TTM) составляет 20.35. В конце 2024 у компании был P/E на уровне 20.25.
История P/E компании Encompass Health Corporation с 2000 по 2026
P/E на конец каждого года
| Год | P/E коэффициент | Изменить |
|---|---|---|
| 2026 (TTM) | 20.35 | 8.00% |
| 2025 | 18.84 | -6.94% |
| 2024 | 20.25 | 7.35% |
| 2023 | 18.86 | -13.86% |
| 2022 | 21.89 | 75.67% |
| 2021 | 12.46 | -45.37% |
| 2020 | 22.81 | 51.59% |
| 2019 | 15.05 | -8.42% |
| 2018 | 16.43 | 14.40% |
| 2017 | 14.36 | 21.73% |
| 2016 | 11.80 | -12.69% |
| 2015 | 13.52 | 13.03% |
| 2014 | 11.96 | 65.79% |
| 2013 | 7.21 | -15.95% |
| 2012 | 8.58 | 36.61% |
| 2011 | 6.28 | 220.22% |
| 2010 | 1.96 | -85.96% |
| 2009 | 13.98 | 387.94% |
| 2008 | 2.86 | 42.39% |
| 2007 | 2.01 | -187.80% |
| 2006 | -2.29 | -33.86% |
| 2005 | -3.46 | -69.48% |
| 2004 | -11.35 | 241.03% |
| 2003 | -3.33 | -31.97% |
| 2002 | -4.89 | -121.51% |
| 2001 | 22.74 | 26.26% |
| 2000 | 18.01 | 0.00% |
P/E для схожих компаний или конкурентов
| Компания | P/E Ratio | Разница P/E | Страна |
|---|---|---|---|
| 15.70 | -22.83% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -48.90% |
US
|
|
| 32.07 | 57.61% |
SA
|
|
| 20.00 | -1.71% |
BR
|
Как читать P/E Ratio?
Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.
Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.
Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.